TLR4 and chronic obstructive pulmonary disease: TLR4 mediates pathogen-induced NF-κB activation in endothelial cells through the homologous structure of the intracellular interleukin-1 receptor (IL-1R) followed by downstream signaling of MyD88, which then secretes immune inflammatory cytokines, and thereby causes COPD.